Angel and Venture Alert: The Case for Investing in Orphan Drugs
No, we’re not talking about developing drugs for orphans. But for 25 million Americans, according to the NIH, an “Orphan Drug” (one that serves fewer than 200k users and includes diseases such as cystic fibrosis, Lou Gehrig’s disease, and Tourette’s...
Why Pay Attention to Blue Gem Coal?
Okay, I know. Most people think of “dirty” coal or the Coal Miner’s Daughter. Understandably so, if those types of coal constitute greater than 95% of all the world’s known coal reserves. Did you know that Blue Gem Coal (and some valuable minerals derived from it) is...
The U.S. Solar market is going mainstream.
It might be surprising to many investors to learn how large and how quickly the solar power market is growing. In 2017, 30% of all new U.S. electric generating capacity came from solar, ranking 2nd only to natural gas.1In 2010, only 4% came from solar. And what may...
